Cargando…
The first long-lived mutants: discovery of the insulin/IGF-1 pathway for ageing
Inhibiting insulin/IGF-1 signalling extends lifespan and delays age-related disease in species throughout the animal kingdom. This life-extension pathway, the first to be defined, was discovered through genetic studies in the small roundworm Caenorhabditis elegans. This discovery is described here.
Autor principal: | Kenyon, Cynthia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001308/ https://www.ncbi.nlm.nih.gov/pubmed/21115525 http://dx.doi.org/10.1098/rstb.2010.0276 |
Ejemplares similares
-
Regulation of Longevity by Insulin/Igf-1 Signaling, Sensory Neurons and the Germline in the Nematode C. Elegans
por: Kenyon, Cynthia
Publicado: (2001) -
Human insulin/IGF-1 and familial longevity at middle age
por: Rozing, Maarten P., et al.
Publicado: (2009) -
FGT‐1‐mediated glucose uptake is defective in insulin/IGF‐like signaling mutants in Caenorhabditis elegans
por: Kitaoka, Shun, et al.
Publicado: (2016) -
The Insulin and IGF-I Pathway in Endocrine Glands Carcinogenesis
por: Malaguarnera, Roberta, et al.
Publicado: (2012) -
Central insulin‐like growth factor‐1 (IGF‐1) restores whole‐body insulin action in a model of age‐related insulin resistance and IGF‐1 decline
por: Huffman, Derek M., et al.
Publicado: (2015)